Search details
1.
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
Acta Neuropathol
; 145(1): 97-112, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36459208
2.
Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome.
J Pediatr Hematol Oncol
; 45(4): e543-e546, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36730977
3.
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
Strahlenther Onkol
; 198(3): 282-290, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34351451
4.
Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes.
J Neurooncol
; 157(2): 307-317, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35147892
5.
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.
J Neurooncol
; 157(1): 37-48, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35190934
6.
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
Strahlenther Onkol
; 197(8): 674-682, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33226469
7.
A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
Pediatr Blood Cancer
; 67(7): e28384, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32383815
8.
Management of Primary Tectal Plate Low-Grade Glioma in Pediatric Patients: Results of the Multicenter Treatment Study SIOP-LGG 2004.
Neuropediatrics
; 49(5): 314-323, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29890518
9.
Correction to: Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes.
J Neurooncol
; 157(2): 319, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35226242
10.
Ventricular Catheter Systems with Subcutaneous Reservoirs (Ommaya Reservoirs) in Pediatric Patients with Brain Tumors: Infections and Other Complications.
Neuropediatrics
; 46(6): 401-9, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26479760
11.
Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol.
J Neurooncol
; 116(3): 567-75, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24407732
12.
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment.
Neuro Oncol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38578306
13.
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa - Results of the HIT 2000 trial.
Neuro Oncol
; 2024 Jun 05.
Article
in English
| MEDLINE | ID: mdl-38835160
14.
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nat Med
; 30(1): 207-217, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37978284
15.
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile.
Neuro Oncol
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38717379
16.
Natural history of a medulloblastoma: 30 months of wait and see in a child with a cerebellar incidentaloma.
Childs Nerv Syst
; 29(7): 1207-10, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23503614
17.
Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma.
Childs Nerv Syst
; 29(8): 1253-62, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23677175
18.
Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
Eur J Cancer
; 178: 171-179, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36455411
19.
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors.
Front Pediatr
; 11: 1183295, 2023.
Article
in English
| MEDLINE | ID: mdl-37292376
20.
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.
Neuro Oncol
; 25(8): 1518-1529, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-36715306